Well Done, LLC Edwards Lifesciences Corp Transaction History

Well Done, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$47.89 - $64.05 $48,799 - $65,266	-1,019 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $47,291 - $58,021	1,019 New	1,019 $156,000
Q2 2018 Aug 03, 2018	SELL	$42.45 - $51.3 $46,270 - $55,917	-1,090 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$37.19 - $47.45 $40,537 - $51,720	1,090 New	1,090 $152,000
Q4 2017 Feb 09, 2018	SELL	$33.79 - $39.39 $327,695 - $382,004	-9,698 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$36.29 - $38.83 $351,940 - $376,573	9,698	9,698 $1.06 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Well Done, LLC, based on Form 13F filings with the SEC.

Stay updated on Well Done, LLC with notifications on news.